Pages that link to "Item:Q6174192"
From MaRDI portal
The following pages link to Simplified within-host and dose-response models of SARS-CoV-2 (Q6174192):
Displaying 8 items.
- The within-host viral kinetics of SARS-CoV-2 (Q2038658) (← links)
- A model for SARS-CoV-2 infection with treatment (Q2223099) (← links)
- A simple in-host model for COVID-19 with treatments: model prediction and calibration (Q2678868) (← links)
- Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors (Q2684584) (← links)
- Why, when and how should exposure be considered at the within-host scale? A modelling contribution to PRRSv infection (Q4968269) (← links)
- Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors (Q6078351) (← links)
- Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: parameter estimates, identifiability, sensitivity and the eclipse phase profile (Q6174182) (← links)
- Modeling identifies variability in SARS-CoV-2 uptake and eclipse phase by infected cells as principal drivers of extreme variability in nasal viral load in the 48 h post infection (Q6174208) (← links)
